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Background
The aim of the evaluation was to investigate the relevance
of the HCV-core antigen testing for the diagnosis and
monitoring of HCV infections in the daily routine. Up to
now, most of the serological diagnostics was performed as
determination of antibodies while the determination of
activity and the monitoring of antiviral therapy were
checked by HCV RNA PCR.
Methods
The routine requests for HCV-core antigen of a private
laboratory were analyzed for a period of two years.
Results
The determination of HCV antigen highly correlates with
the quantitative measurement of HCV RNA (r=0.73),
p=0.0003). The diagnostic window is comparable with that
of the HCV PCR (27.1 ± 12.8 d vs. 23.9 ± 9.2 d, p=0.11).
The sensitivity of the HCV antigen assay was 99.0 % with
a specificity of 99.2 %. 54.3 % of the confirmed antibody
positive samples were also antigen positive. Only in 3 of
560 HCV-RNA positive samples HCV antigen was not
detectable, but 3 samples without HCV antibodies were
confirmed positive for HCV antigen.
Conclusions
The HCV antigen assay is a suitable tool for the detection
of chronic active HCV infections, for the early diagnosis
of acute infections and for testing of HCV in patient with
immunodeficiency. The HCV antigen assay valuable
completion of serological testing for HCV.
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